Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants

NCT05107492 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammatory Bowel Disease

Interventions

DRUG: 450mg
DRUG: 150mg
DRUG: Placebo

Sponsor

Pfizer